Stay updated on Denosumab + PD-1 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Denosumab + PD-1 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab + PD-1 in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:10:35.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    An NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:39:51.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:38:22.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message in place of the study content, indicating access is blocked to the study record.
    Difference
    20%
    Check dated 2026-09-22T23:58:23.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added and Revision: v3.6.6 was removed, indicating a new build/version label on the page.
    Difference
    0.1%
    Check dated 2026-09-15T23:38:43.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5, indicating a new version of the study's documentation.
    Difference
    0.1%
    Check dated 2026-09-01T20:26:47.000Z thumbnail image

Stay in the know with updates to Denosumab + PD-1 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab + PD-1 in Melanoma Clinical Trial page.